NCT05202587View on ClinicalTrials.gov

The Evaluation of the Agreement Between the NVHO in the Automatic Fluid Quantification and Cirrus OCT

CompletedOBSERVATIONAL
Enrollment

386

Participants

Timeline

Start Date

November 10, 2021

Primary Completion Date

January 12, 2023

Study Completion Date

January 12, 2023

Conditions
Neovascular Age-related Macular Degeneration
Trial Locations (5)

32806

Florida Retina Institute, PA, Orlando

37203

Tennessee Retina, PC, Nashville

45242

Cincinnati Eye Institute, Cincinnati

76087

Strategic Clinical Research Group, Willow Park

80228

Brian Joondeph, Lakewood

Sponsors

Lead Sponsor

Notal Vision Inc.
All Listed Sponsors
lead

Notal Vision Inc.

INDUSTRY

NCT05202587 - The Evaluation of the Agreement Between the NVHO in the Automatic Fluid Quantification and Cirrus OCT | Biotech Hunter | Biotech Hunter